New York State Common Retirement Fund Karyopharm Therapeutics Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$0.87 - $1.58 $17,569 - $31,908	-20,195 Reduced 95.48%	955 $1,000
Q1 2024 May 07, 2024	BUY	$0.72 - $1.66 $1,279 - $2,949	1,777 Added 9.17%	21,150 $32,000
Q4 2023 Feb 01, 2024	SELL	$0.68 - $1.31 $197 - $379	-290 Reduced 1.47%	19,373 $17,000
Q3 2023 Nov 07, 2023	BUY	$1.14 - $1.81 $802 - $1,274	704 Added 3.71%	19,663 $26,000
Q2 2023 Aug 07, 2023	SELL	$1.79 - $4.59 $205 - $527	-115 Reduced 0.6%	18,959 $34,000
Q1 2023 May 02, 2023	SELL	$2.84 - $3.92 $85,200 - $117,600	-30,000 Reduced 61.13%	19,074 $74,000
Q4 2022 Jan 30, 2023	SELL	$2.48 - $5.93 $45,463 - $108,708	-18,332 Reduced 27.2%	49,074 $167,000
Q3 2022 Nov 08, 2022	BUY	$4.08 - $5.82 $75,610 - $107,856	18,532 Added 37.92%	67,406 $368,000
Q2 2022 Aug 04, 2022	SELL	$4.15 - $8.37 $14,736 - $29,721	-3,551 Reduced 6.77%	48,874 $220,000
Q1 2022 May 05, 2022	BUY	$5.91 - $14.38 $58,101 - $141,369	9,831 Added 23.08%	52,425 $386,000
Q4 2021 Feb 02, 2022	SELL	$5.21 - $8.61 $864 - $1,429	-166 Reduced 0.39%	42,594 $274,000
Q3 2021 Nov 02, 2021	SELL	$4.45 - $10.63 $73,603 - $175,820	-16,540 Reduced 27.89%	42,760 $249,000
Q2 2021 Aug 02, 2021	SELL	$8.11 - $11.11 $126,313 - $173,038	-15,575 Reduced 20.8%	59,300 $612,000
Q1 2021 May 11, 2021	SELL	$9.85 - $17.69 $54,175 - $97,295	-5,500 Reduced 6.84%	74,875 $788,000
Q3 2020 Nov 05, 2020	SELL	$14.14 - $19.71 $90,849 - $126,636	-6,425 Reduced 7.4%	80,375 $1.17 Million
Q2 2020 Aug 07, 2020	BUY	$16.6 - $25.25 $429,442 - $653,217	25,870 Added 42.46%	86,800 $1.64 Million
Q4 2019 Feb 05, 2020	BUY	$9.23 - $19.67 $16,890 - $35,996	1,830 Added 3.1%	60,930 $1.17 Million
Q3 2019 Nov 07, 2019	BUY	$5.66 - $11.85 $82,636 - $173,010	14,600 Added 32.81%	59,100 $569,000
Q4 2018 Feb 08, 2019	SELL	$8.2 - $16.95 $77,080 - $159,330	-9,400 Reduced 17.44%	44,500 $417,000
Q2 2018 Aug 10, 2018	BUY	$12.0 - $19.88 $194,400 - $322,056	16,200 Added 42.97%	53,900 $916,000
Q1 2018 May 10, 2018	BUY	$9.92 - $17.25 $71,424 - $124,200	7,200 Added 23.61%	37,700 $506,000
Q3 2017 Nov 06, 2017	BUY	$8.15 - $11.16 $18,745 - $25,668	2,300 Added 8.16%	30,500 $335,000
Q2 2017 Aug 11, 2017	BUY	N/A	28,200	28,200 $255,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.55 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.27 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.76 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account